Literature DB >> 23174246

The predictive value of a cystocele for concomitant vaginal apical prolapse.

Christopher S Elliott1, Judy Yeh, Craig V Comiter, Bertha Chen, Eric R Sokol.   

Abstract

PURPOSE: Recent studies showing a correlation between descent of the anterior and apical vaginal compartments suggest that cystoceles may recur if associated apical prolapse is not corrected. However, to date the anatomical relationship of apical prolapse with respect to cystocele has been incompletely reported. We present the predictive value of a cystocele for clinically significant vaginal apical prolapse.
MATERIALS AND METHODS: We retrospectively reviewed the records of all new patient visits to a urogynecology clinic in a 30-month period. Women with a point Ba value of -1 or greater (stage 2 cystocele and above) were included in analysis. Predictive values of clinically significant apical prolapse, defined as point C -3 or greater, were calculated and stratified by cystocele stage.
RESULTS: A total of 385 women were included in study. Point Ba was the leading edge of prolapse in 83.9% of cases. The position of Ba strongly correlated with that of the vaginal apex (Spearman ρ = 0.769, p <0.001). Overall 59.7% of patients had a point C of -3 or greater. The finding of clinically significant apical prolapse increased significantly with increasing Ba values. Of patients with stage 2, 3 and 4 cystocele point C was -3 or greater in 42%, 85% and 100%, respectively.
CONCLUSIONS: The finding of stage 2 or greater cystocele is highly suggestive of clinically significant apical vaginal descent to -3 or greater. Furthermore, as cystocele stage increases, the predictive value of apical prolapse also increases. Surgeons contemplating cystocele repair should have high suspicion for vaginal apical prolapse and consider concomitant repair.
Copyright © 2013 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23174246     DOI: 10.1016/j.juro.2012.08.177

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  7 in total

1.  Concomitant apical suspensory procedures in women with anterior vaginal wall prolapse in the United States in 2011.

Authors:  Gina M Northington; Catherine O Hudson; Deborah R Karp; Sarah A Huber
Journal:  Int Urogynecol J       Date:  2015-12-02       Impact factor: 2.894

2.  Utilization of apical vaginal support procedures at time of inpatient hysterectomy performed for benign conditions: a national estimate.

Authors:  Whitney Trotter Ross; Melanie R Meister; Jonathan P Shepherd; Margaret A Olsen; Jerry L Lowder
Journal:  Am J Obstet Gynecol       Date:  2017-07-14       Impact factor: 8.661

3.  The hybrid technique of pelvic organ prolapse treatment: apical sling and subfascial colporrhaphy.

Authors:  Dmitry Shkarupa; Nikita Kubin; Alexey Pisarev; Anastasiya Zaytseva; Ekaterina Shapovalova
Journal:  Int Urogynecol J       Date:  2017-02-17       Impact factor: 2.894

4.  Improving the accuracy of prolapse and incontinence procedure epidemiology by utilizing both inpatient and outpatient data.

Authors:  Christopher S Elliott; Kim F Rhoads; Craig V Comiter; Bertha Chen; Eric R Sokol
Journal:  Int Urogynecol J       Date:  2013-05-03       Impact factor: 2.894

Review 5.  Current surgical management of pelvic organ prolapse: Strategies for the improvement of surgical outcomes.

Authors:  Kwang Jin Ko; Kyu-Sung Lee
Journal:  Investig Clin Urol       Date:  2019-10-29

Review 6.  Comparison of the effectiveness of sacrospinous ligament fixation and sacrocolpopexy: a meta-analysis.

Authors:  Wenju Zhang; Willy Cecilia Cheon; Li Zhang; Xiaozhong Wang; Yuzhen Wei; Chaoxia Lyu
Journal:  Int Urogynecol J       Date:  2021-06-03       Impact factor: 1.932

7.  Predictors of Clinical Outcome in Women with Pelvic Organ Prolapse Who Underwent Transvaginal Mesh Reconstruction Surgery.

Authors:  Ting-Hsuan Lin; Fung-Chao Tu; Ho-Hsiung Lin; Sheng-Mou Hsiao
Journal:  Medicina (Kaunas)       Date:  2022-01-19       Impact factor: 2.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.